The global digital pathology market was valued US$ 1.07 billion in 2022 and is expected to reach approximately US$ 2.7 billion by 2032, growing at a compound annual growth rate (CAGR) of 10% during the forecast period 2023-2032.

Advancements in hereditary genetic testing are quickly evolving, with significant effects on the future of health care.

Obstructive sleep apnea (OSA) affects roughly one out of every five people in the United States and it is estimated that 85% of people suffering from OSA are underdiagnosed (Santilli, et al., 2021).

In recent years, direct-to-consumer (DTC) wellness testing has become a growing trend, and the COVID-19 pandemic has accelerated its adoption. With people looking for ways to monitor their health from the comfort of their homes, DTC wellness testing has become a popular solution.

Nucleic acid sample preparation is a crucial part of molecular biology research as it lays the foundation for downstream molecular biology applications. The quality and quantity of the purified DNA or RNA obtained from the biological sample determine the success of subsequent experiments.

The global genetic testing market is expected to grow from nearly $17.5 billion in 2023 to over $25 billion by 2027 at a compound annual growth rate (CAGR) of above 10%, as per The Business Research Company’s Genetic Testing Global Market Report 2022.

The field of genomics has significantly positioned itself as a hotspot of academic scientific research and clinical medicine. Precision medicine and next-generation sequencing (NGS) are two examples of technological developments that have initiated substantial advancements in the field of oncology while also creating new opportunities for further growth.

In-vitro diagnostic (IVD) tests are performed on human bodily tissues or blood samples to detect diseases or disorders, or to monitor a person’s overall health to treat, prevent, or cure diseases.

Artificial intelligence is omnipresent. In the future, queries will be responded to by personal digital assistants, trade stocks will be monitored by robo-advisors, and driverless cars will drive people to their destinations.

A solid lump on a person’s body is generally a cause of concern, as in some cases, it is found to be cancerous or has the probability of becoming cancerous if not treated in time.